The pharmaceutical most often used in Norway during 2023 was atorvastatin, also known under its original brand name Lipitor, with more than 49 defined daily doses per person. Acetylsalisylsyre (Albyl-E) followed, with 20 defined daily doses per person.
Leading pharmaceuticals in Norway based on usage in 2023
(in DDD per capita)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Apotekforeningen. (March 25, 2024). Leading pharmaceuticals in Norway based on usage in 2023 (in DDD per capita) [Graph]. In Statista. Retrieved December 19, 2024, from https://www.statista.com/statistics/1214348/top-drugs-sold-in-norway-by-usage/
Apotekforeningen. "Leading pharmaceuticals in Norway based on usage in 2023 (in DDD per capita) ." Chart. March 25, 2024. Statista. Accessed December 19, 2024. https://www.statista.com/statistics/1214348/top-drugs-sold-in-norway-by-usage/
Apotekforeningen. (2024). Leading pharmaceuticals in Norway based on usage in 2023 (in DDD per capita) . Statista. Statista Inc.. Accessed: December 19, 2024. https://www.statista.com/statistics/1214348/top-drugs-sold-in-norway-by-usage/
Apotekforeningen. "Leading Pharmaceuticals in Norway Based on Usage in 2023 (in Ddd per Capita) ." Statista, Statista Inc., 25 Mar 2024, https://www.statista.com/statistics/1214348/top-drugs-sold-in-norway-by-usage/
Apotekforeningen, Leading pharmaceuticals in Norway based on usage in 2023 (in DDD per capita) Statista, https://www.statista.com/statistics/1214348/top-drugs-sold-in-norway-by-usage/ (last visited December 19, 2024)
Leading pharmaceuticals in Norway based on usage in 2023 (in DDD per capita) [Graph], Apotekforeningen, March 25, 2024. [Online]. Available: https://www.statista.com/statistics/1214348/top-drugs-sold-in-norway-by-usage/
